Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,500 shares at $800.00 ($1.2M) on 2026-01-07, disclosed to the SEC on 2026-01-08.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |
| REGN | SELL | 2024-06-07 | $836K | — | Filing → |